Insight

Integrative Multi-Omic Profiling of Triple Negative Breast Cancer – Dana-Farber’s Breast Oncology Center

Photo taken from Bojana Jovanovic/LinkedIn

Aug 26, 2024, 21:21

Integrative Multi-Omic Profiling of Triple Negative Breast Cancer – Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X:

“This new study examines integrative multi-omic profiling of Triple Negative Breast Cancer for identifying suitable therapies. Rachel Freedman are leading efforts to improve access to clinical trials and to ensure that research reflects all communities.”

Integrative multi-omic profiling of triple-negative breast cancer for identifying suitable therapies

Authors: Bojana Jovanovic, Sarah E Church, Kara M Gorman, Khrystyna North, Edward T Richardson, Molly DiLullo, Victoria Attaya, Julie Kasparian, Ayesha Mohammed-Abreu, Gregory Kirkner, Melissa E Hughes, Nancy U Lin, Elizabeth A Mittendorf, Stuart J Schnitt, Sara M Tolaney, Shom Goel.

Integrative Multi-Omic Profiling of Triple Negative Breast Cancer - Dana-Farber’s Breast Oncology Center

Source: Dana-Farber’s: Breast Oncology Center/X

Ayesha Mohammed-Abreu Bojana Jovanovic Breast Oncology Center cancer Cancer research clinical trials Dana-Farber Edward T Richardson Elizabeth A. Mittendorf Gregory Kirkner integrative multi-omic profiling Julie Kasparian Kara M Gorman Khrystyna North Melissa E Hughes Molly DiLullo Nancy U Lin OncoDaily Oncology Rachel Freedman Sara M. Tolaney Sarah E Church Shom Goel Stuart J Schnitt TNBC triple-negative breast cancer Victoria Attaya

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth